Data from a randomized and controlled trial of LCarnitine prescription for the treatment for Non- Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) consists of a range of complication. The disease describes clinical , para clinical and pathological conditions from simple steatosis in non-alcoholic steato hepatitis (NASH) to fibrosis, cirrhosis and hepato cellular carcinoma. Therefore, it is of interest...

Descripción completa

Detalles Bibliográficos
Autores principales: Somi, Mohamad Hosein, Fatahi, Ebrahim, Panahi, Jafar, Havasian, Mohamad Reza, judaki, Arezo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2014
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209366/
https://www.ncbi.nlm.nih.gov/pubmed/25352725
http://dx.doi.org/10.6026/97320630010575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209366/
https://www.ncbi.nlm.nih.gov/pubmed/25352725
http://dx.doi.org/10.6026/97320630010575

Ejemplares similares